Companies / Design Therapeutics, Inc.

Design Therapeutics, Inc.

Nasdaq: DSGNCIK 1807120CARLSBAD, CA

Financials · FY2025

Revenue$0
Net income$-69.79M
Total debt
Cash$12.91M
Diluted EPS$-1.22
Shares outstanding62.6M

Ownership

62.6M shares outstanding · as of Jul 29, 2026
64.9%Institutions
Ownership
Institutions64.88%40,603,041
Public float35.12%21,978,610

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Burgess JulieChief Accounting Officer
Jeffries SeanChief Operating Officer
Shah PratikCEOPresident, CEO and Chairperson · Director
Storgard ChrisChief Medical Officer

Institutional holders 118

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 2, 2026Jeffries Sean
Executive
GrantStock option (right to buy)+375K
375,000
0.60% of shares
low
Jan 2, 2026Burgess Julie
Executive
GrantStock option (right to buy)+150K
150,000
0.24% of shares
low
Jan 2, 2026Gover Justin D.
Director
GrantStock option (right to buy)+45K
45,000
0.07% of shares
low
Jan 2, 2026Storgard Chris
Executive
GrantStock option (right to buy)+250K
250,000
0.40% of shares
low
Jan 2, 2026Shah Pratik
CEO
GrantStock option (right to buy)+750K
750,000
1.20% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Point72 Asset Management, L.P.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DSGNCommon StockEquity25056L103BBG00SNC49V8